A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada

A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada

Introduction: The real-world data evaluating treatment outcomes of atezolizumab plus carboplatin-etoposide chemotherapy (atezolizumab) for extensive-stage SCLC (ESCLC) are lacking. Our objective was to evaluate real-world outcomes of ESCLC treated with atezolizumab. Methods: A retrospective analysis...

Full description

Bibliographic Details
Main Authors: Anifat A. Elegbede, MSc, MbChB, Amanda J. Gibson, BSc, Andrea S. Fung, PhD, MD, Winson Y. Cheung, MD, MPH, Michelle L. Dean, BSc, D. Gwyn Bebb, BMBCh, PhD, Aliyah Pabani, MD
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:JTO Clinical and Research Reports
Subjects:
Extensive stage SCLC
Chemo-immunotherapy
Thoracic radiation
Survival outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364321001089

Internet

http://www.sciencedirect.com/science/article/pii/S2666364321001089

Similar Items